Femasys announces notices of intention to grant 2 European patent applications

Femasys (FEMY) announces the European Patent Office, EPO, issued notices of Intention to Grant for two EU Patent Applications, EPO Application Nos. 24170531.8 and 18751753.7, which will have anticipated expirations in 2039 and 2038, respectively. Femasys plans to pursue additional patent applications to further strengthen its existing portfolio protecting FemBloc permanent birth control, along with its other products, including FemaSeed, FemVue, FemCath and FemCerv.